From the Department of Radiology, Ajou University Hospital, Ajou University School of Medicine, Suwon.
Department of Radiology, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
Invest Radiol. 2021 Feb 1;56(2):109-116. doi: 10.1097/RLI.0000000000000714.
The aim of this study was to assess the benefit of adding arterial subtraction images from computed tomography (CT) to the Liver Imaging Reporting and Data System (LI-RADS) v2018 treatment response (LR-TR) categorization in patients treated with transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC).
This retrospective study included 115 patients with 151 HCCs treated by TACE using an emulsion of doxorubicin and iodized oil who underwent multiphasic CT protocol that additionally generated arterial subtraction images based on nonrigid anatomic correction algorithm. Of 151 HCCs, 67 (44.4%) were viable and 84 (55.6%) were nonviable. Two independent readers assessed the per-lesion LR-TR categories in set 1 of multiphasic CT images alone and set 2 including both set 1 and CT arterial subtraction images, besides diagnostic confidence, and the quality of subtraction images. The sensitivity and specificity of LR-TR viable category between the sets were compared using the generalized estimating equation. Interobserver agreements of LR-TR categorization in each set and the quality of subtraction images were assessed by Cohen κ.
The quality of subtraction images was mostly good to perfect (98.7%) with good interobserver agreement (κ = 0.71), and none were nondiagnostic. For detecting viable HCC, LR-TR viable category showed sensitivity of 53.7% to 56.7% and specificity of 96.4% to 98.8% in set 1. In comparison, set 2 showed significantly higher sensitivity of 88.1% to 89.6% (P < 0.002) and equivalent specificity of 94% to 95.2% (P > 0.13) for the same category. In sets 1 and 2, 31.3% to 34.3% and 9% to 10.4% of viable HCC were miscategorized as LR-TR nonviable, respectively. LR-TR equivocal category was less assigned in set 2 (1.3%) than in set 1 (6.6%-7.9%). Set 2 showed slightly higher level of confidence for LR-TR categorization compared with set 1 (3.4 ± 0.8 vs 3.8 ± 0.5). Interobserver agreement was excellent in both sets (κ = 0.85 in set 1 and 0.97 in set 2).
The LR-TR viable category is highly specific but inadequately sensitive for detecting viable tumor in TACE-treated HCC on conventional multiphasic CT. Adding arterial subtraction images to the conventional CT images significantly increases sensitivity without compromising the specificity and improves the diagnostic confidence of LR-TR viable category.
本研究旨在评估在接受经导管动脉化疗栓塞(TACE)治疗的肝细胞癌(HCC)患者中,将 CT 动脉减影图像添加到肝脏成像报告和数据系统(LI-RADS)v2018 治疗反应(LR-TR)分类中对治疗反应的影响。
本回顾性研究纳入了 115 例接受多相 CT 协议检查的 151 个 HCC 患者,该协议使用多柔比星和碘化油乳剂进行 TACE,并根据非刚性解剖校正算法生成动脉减影图像。151 个 HCC 中,67 个(44.4%)为存活肿瘤,84 个(55.6%)为非存活肿瘤。两名独立的读者在多相 CT 图像的第一组(set 1)和包含第一组和 CT 动脉减影图像的第二组(set 2)中评估每例肿瘤的 LR-TR 类别,并评估诊断信心和减影图像质量。使用广义估计方程比较两组间 LR-TR 存活类别的敏感性和特异性。采用 Cohen κ 评估每组的 LR-TR 分类的观察者间一致性和减影图像的质量。
减影图像的质量大多为良好至极好(98.7%),具有良好的观察者间一致性(κ=0.71),且无不可诊断图像。在检测存活 HCC 方面,LR-TR 存活类别的敏感性在 set 1 中为 53.7%至 56.7%,特异性为 96.4%至 98.8%。相比之下,set 2 显示出显著更高的敏感性(88.1%至 89.6%)(P<0.002),且相同类别的特异性相当(94%至 95.2%)(P>0.13)。在 set 1 和 set 2 中,分别有 31.3%至 34.3%和 9%至 10.4%的存活 HCC 被错误归类为 LR-TR 非存活肿瘤。set 2 中 LR-TR 不确定类别(1.3%)比 set 1(6.6%-7.9%)少。与 set 1 相比,set 2 对 LR-TR 分类的信心水平略高(3.4±0.8 比 3.8±0.5)。两组观察者间一致性均为优秀(set 1 为 κ=0.85,set 2 为 κ=0.97)。
在常规多相 CT 上,LR-TR 存活类别的特异性较高,但对检测 TACE 治疗后的 HCC 存活肿瘤的敏感性不足。将动脉减影图像添加到常规 CT 图像中可显著提高敏感性,而不影响特异性,并提高 LR-TR 存活类别的诊断信心。